Metoclopramide
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
A dopamine D2 receptor antagonist and prokinetic agent used for the treatment of GERD, diabetic gastroparesis, and prevention of nausea and vomiting associated with chemotherapy and surgery. Metoclopramide enhances upper GI motility and has central antiemetic activity, but carries a risk of tardive dyskinesia with prolonged use.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
A dopamine D2 receptor antagonist and prokinetic agent used for the treatment of GERD, diabetic gastroparesis, and prevention of nausea and vomiting associated with chemotherapy and surgery. NutriStack rates the supporting evidence as strong. Common adult dosing is 5–10 mg three to four times daily, 30 minutes before meals; maximum 12 weeks of use recommended (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: acceleration of gastric emptying in gastroparesis, relief of gerd symptoms, prevention of chemotherapy-induced nausea. 10 sources indexed (2016–2024), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Blocks dopamine D2 receptors centrally in the chemoreceptor trigger zone (antiemetic effect) and peripherally in the GI tract (prokinetic effect). It also enhances the response to acetylcholine in the upper GI tract, increasing gastric contractions, raising lower esophageal sphincter tone, and accelerating gastric emptying. At higher doses, it also antagonizes 5-HT3 receptors.
Dosing & protocol.
Take 30 minutes before meals and at bedtime for gastroparesis
Full safety detail.
Side effects
- Drowsiness and fatigue
- Restlessness and akathisia
- Tardive dyskinesia (with prolonged use)
- Extrapyramidal symptoms (dystonia, parkinsonism)
- Diarrhea
- Hyperprolactinemia (galactorrhea, gynecomastia, amenorrhea)
- Depression
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
7- 1Efficacy and safety of domperidone and metoclopramide on human milk production in postpartum mothers: a bayesian network meta-analysis of randomized controlled trialsPMIDSi S, Zhao G, Song G et al. · BMC pregnancy and childbirth · 2024
Si S, Zhao G, Song G et al.. Efficacy and safety of domperidone and metoclopramide on human milk production in postpartum mothers: a bayesian network meta-analysis of randomized controlled trials. BMC pregnancy and childbirth. 2024
- 2Intravenous ketorolac versus metoclopramide in adult patients with migraine headaches: An updated systematic review and meta-analysisPMIDSong Q, Yang H, Yang X · Advances in clinical and experimental medicine : official organ Wroclaw Medical University · 2024
Song Q, Yang H, Yang X. Intravenous ketorolac versus metoclopramide in adult patients with migraine headaches: An updated systematic review and meta-analysis. Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 2024
- 3Efficacy of acupoint injection of metoclopramide for post-chemotherapy vomiting: A systematic review and meta-analysisPMIDAi M, Cai Y, Zeng Y et al. · Medicine · 2024
Ai M, Cai Y, Zeng Y et al.. Efficacy of acupoint injection of metoclopramide for post-chemotherapy vomiting: A systematic review and meta-analysis. Medicine. 2024
- 4The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trialsPMIDAbdelmonem H, Abdelhay HM, Abdelwadoud GT et al. · BMC neurology · 2023
Abdelmonem H, Abdelhay HM, Abdelwadoud GT et al.. The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials. BMC neurology. 2023
- 5Risk of Adverse Events Associated with Domperidone and Metoclopramide in Gastroparesis: Systematic Review and Meta-analysisPMIDJunqueira DR, Bennett D, Huh SY et al. · Drugs in R&D · 2023
Junqueira DR, Bennett D, Huh SY et al.. Risk of Adverse Events Associated with Domperidone and Metoclopramide in Gastroparesis: Systematic Review and Meta-analysis. Drugs in R&D. 2023
- 6Efficacy and Safety of Domperidone and Metoclopramide in Breastfeeding: A Systematic Review and Meta-AnalysisPMIDShen Q, Khan KS, Du MC et al. · Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine · 2021
Shen Q, Khan KS, Du MC et al.. Efficacy and Safety of Domperidone and Metoclopramide in Breastfeeding: A Systematic Review and Meta-Analysis. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine. 2021
- 7The Safety of Metoclopramide in Children: A Systematic Review and Meta-AnalysisPMIDLau Moon Lin M, Robinson PD, Flank J et al. · Drug safety · 2016
Lau Moon Lin M, Robinson PD, Flank J et al.. The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis. Drug safety. 2016
Reference material
3- 8Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010.Source linkedPMID
- 9Parkman HP et al. Effect of nightly metoclopramide on gastroparesis symptoms. Am J Gastroenterol. 2013.Source linkedPMID
- 10Onodera R et al. Extrapyramidal symptoms and effectiveness of continuous vs bolus intravenous metoclopramide: A systematic review and meta-analysis. Am J Emerg Med. 2026.Source linkedPMID
Common questions.
Quick answers about Metoclopramide, drawn from the data on this page.
What is Metoclopramide?
A dopamine D2 receptor antagonist and prokinetic agent used for the treatment of GERD, diabetic gastroparesis, and prevention of nausea and vomiting associated with chemotherapy and surgery. Metoclopramide enhances upper GI motility and has central antiemetic activity, but carries a risk of tardive dyskinesia with prolonged use.
What is Metoclopramide used for?
Commonly cited benefits of Metoclopramide include: Acceleration of gastric emptying in gastroparesis; Relief of GERD symptoms; Prevention of chemotherapy-induced nausea; Prevention of postoperative nausea and vomiting. NutriStack rates the overall evidence as strong.
What is a typical dose of Metoclopramide?
A typical adult dose of Metoclopramide is 5–10 mg three to four times daily, 30 minutes before meals; maximum 12 weeks of use recommended (as prescribed by your physician). The commonly recommended form is Tablet, oral solution, or IV/IM injection. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Metoclopramide?
Reported side effects include drowsiness and fatigue, restlessness and akathisia, tardive dyskinesia (with prolonged use), extrapyramidal symptoms (dystonia, parkinsonism), diarrhea, hyperprolactinemia (galactorrhea, gynecomastia, amenorrhea). This is educational information; check with a healthcare professional before use.
How strong is the evidence for Metoclopramide?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Metoclopramide in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.